Amarin to declare preliminary Q1 results April 13 (NASDAQ:AMRN)

Amarin (NASDAQ:AMRN) will sponsor a conference call on Monday, April 13, in 4:30 pm ET to supply preliminary Q1 results and also to upgrade its operations, such as its projected appeal of this adverse patent linked to Vascepa (icosapent ethyl).

Present consensus is a loss/share of ($0. 09) on earnings of 129M.

exemptions 1 percent later.

Facebook Comments

Leave a Reply

Your email address will not be published. Required fields are marked *